accountfrom a weaker dollar that boosted the value of sales abroad, new products obtained by the purchase of King Pharmaceuticals and a sharply lower tax rate. Large U.S. rivals also topped first-quarter forecasts, helped by a weaker dollar and cost cuts, with...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 6-Pfizer drug sales fall, lower-margin units shine
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account